| Authors: |
Murayama T; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Meador CB; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Ivanova EV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Pan Y; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Knelson EH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nakayama J; Department of Oncogenesis and Growth Regulation, Osaka International Cancer Institute, Osaka, Japan.; Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan., Ma X; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hung YP; Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Kim W; Moores Cancer Center, UC San Diego, La Jolla, California.; Center for Novel Therapeutics, UC San Diego, La Jolla, California.; Department of Medicine, UC San Diego, La Jolla, California., Watanabe H; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Cai KQ; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hata AN; Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cañadas I; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania. |
